U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Headline
The Substance Abuse and Mental Health Services Administration July 27 released results from its latest national survey on drug use and mental health. The…
Headline
The AHA’s Bridge to Care initiative highlights how hospitals and health systems are strengthening care transitions and supporting ongoing treatment engagement…
Headline
In this conversation, a team from the University Medical Center New Orleans — LSU School of Medicine’s Benjamin Springgate, M.D., professor of …
Headline
Heidi Bray, DNP, nurse practitioner and hospitalist at Providence St. Peter Hospital, explores how hospitals can improve opioid use disorder treatment through…
Headline
The AHA will host a webinar June 16 at 1 p.m. ET that will share insights from its Bridge to Care Toolkit, designed to help hospitals and health systems…
Headline
The Drug Enforcement Administration today released a final rule implementing provisions from the Restoring Hope for Mental Health and Well-Being Act of 2022,…